| Authors: |
Muiser S; Department of Pulmonology, University Medical Centre Groningen, Groningen, Netherlands s.muiser@umcg.nl.; University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD, Groningen, Netherlands., Müllerová H; Respiratory & Immunology, Medical and Payer Evidence Strategy, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK., Belton L; BioPharmaceuticals Medical, AstraZeneca, Cambridge, England, UK., Rusibamayila N; BioPharmaceuticals Medical, AstraZeneca, Cambridge, England, UK., Erhard C; BioPharmaceuticals Medical, AstraZeneca, Cambridge, England, UK., Agusti A; Respiratory Institute, Clinic Barcelona, FCRB-IDIBAPS, CIBERES, Catedra Salud Respiratoria, University of Barcelona, Barcelona, Spain., Faner R; Respiratory Institute, Clinic Barcelona, FCRB-IDIBAPS, CIBERES, Catedra Salud Respiratoria, University of Barcelona, Barcelona, Spain., Pavord I; Respiratory Medicine Unit and Oxford Respiratory NIHR BRC, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK., Couillard S; Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke, Sherbrooke, Quebec, Canada., Inoue H; Graduate School of Medical and Dental Sciences, Department of Pulmonary Medicine, Kagoshima University, Kagoshima, Japan., Price DB; Observational and Pragmatic Research Institute, Singapore.; Centre of Academic Primary Care, Division of Applied Health Sciences, University of Aberdeen, Aberdeen, UK., Olaguibel JM; Servicio de Alergología, Hospital Universitario de Navarra, Pamplona, Spain., Kerstjens HAM; Department of Pulmonology, University Medical Centre Groningen, Groningen, Netherlands., van den Berge M; Department of Pulmonology, University Medical Centre Groningen, Groningen, Netherlands. |
